Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, has announced European CE mark approval of the Dual Energy THERMOCOOL SMARTTOUCH SF Catheter for the treatment of cardiac arrhythmias. The Dual Energy THERMOCOOL SMARTTOUCH SF Catheter is an irrigated, contact-force sensing catheter powered by the TRUPULSE Generator, and is fully integrated with the CARTO 3 System for electro-anatomical mapping and for tag indexing. The company expects TRUPULSE Generator hardware compatibility in the first half of 2025. When fully approved, the platform will provide electrophysiologists with the ability to switch between radiofrequency (RF) and pulsed field (PF) energy in the same catheter they know and trust. The Dual Energy THERMOCOOL SMARTTOUCH SF Catheter is not currently approved in the United States. The Dual Energy THERMOCOOL SMARTTOUCH SF Catheter is designed on the same platform as the radiofrequency THERMOCOOL SMARTTOUCH SF Catheter – the most commonly used catheter in the world today, with many years of physician experience.
“As the number of people with AFib grows around the world, physicians are looking for integrated and flexible tools to help deliver safe, effective and efficient cardiac ablation procedures,” said Tom De Potter, MD, Head of Electrophysiology and Associate Director of the Heart Centre, OLV Hospital, Aalst, Belgium. “Both PF and RF energy have important advantages in clinical practice. With the Dual Energy THERMOCOOL SMARTTOUCH SF Catheter, having the ability to easily switch between RF and PF energy provides the flexibility to customise treatment depending on the patient anatomy and clinical need, enabling electrophysiologists to perform more targeted ablation procedures which could lead to improved outcomes for patients.”
